Research Interests
Immune microenviroment in gynecologic malignancies, novel therapies for ovarian and uterine cancer, PARP inhibition in uterine cancer, molecular testing of gynecologic malignancies, early Phase clinical trials
Selected Grants
Duke-UNC-Wash U Partnership for Early Phase Clinical Trials in Cancer
Clinical TrialSignificant Contributor · Awarded by National Institutes of Health · 2014 - 2023Use of an oncolytic adenovirus to promote anti-tumor T-cell responses in ovarian cancer
ResearchMentor · Awarded by Foundation for Women's Cancer · 2022 - 2023Adrenergic signaling inhibition to enhance the immunogenicity of the ovarian tumor microenvironment prior to PD-1 checkpoint therapy
ResearchPrincipal Investigator · Awarded by Ponce Health Sciences University · 2020 - 2022Molecular classification of endometrial advanced stage cancers and association with survival outcomes: Ancillary analysis of GOG-0258
ResearchCo Investigator · Awarded by American Association of Obstetricians and Gynecologists Foundation · 2021 - 2022Are ESR1 mutations associated with shorter progression free survival in copy number-low endometrial adenocarcinomas?
ResearchCollaborating Investigator · Awarded by Foundation for Women's Cancer · 2020 - 2022Fellowships, Gifts, and Supported Research
Exploring the immune contexture of molecularly characterized uterine cancers ·
2019
- 2022
PI ·
Awarded by: Goldman Sachs Philanthropy Fund/Emerson Collective Fund
Prospective randomized trial of streamlined genetic education and testing for ovarian, fallopian and peritoneal cancer patients ·
2019
- 2021
Awarded by: Gray Foundation
Molecular classification of medically managed endometrial tumors ·
2018
Awarded by: Charles Hammond Research Fund
· $10,000.00
Janet Burros Ovarian Cancer Repository in collaboration with the Cancer Data Initiative ·
2018
Awarded by: Janet Burros Memorial Foundation
T32 Training Grant ·
2013
- 2015
Awarded by: NCI-DHHS-NIH
External Relationships
- LabCorp (Laboratory Corp of America)
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.